Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Wei Xu, explained in plain language.
This study is testing if adding a new oral drug, golidocitinib, to a standard chemotherapy and immunotherapy combination works better for people with newly diagnosed, advanced NK/T-cell lymphoma. It will compare the new three-drug combination against the standard two-drug combina…
Phase: PHASE2 • Sponsor: WEI XU • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC